Note that in an independent group of samples collected at the Lille University Hospital Center, which included 7 G2019S carriers with PD, we also observed the increase of total-LRRK2 levels in G2019S carriers relative to non-carriers (Fig. 3), lending inherent validity to our observations. The gene discussed is LRRK2; the disease is Parkinson disease.